Hormonal replacement therapy | SOP Information, SOPs and Supporting Information – alphabetic listing, M, Malignant Neoplasm of the Endometrium B045, Rulebase for malignant neoplasm of the endometrium

You are here

Hormonal replacement therapy

Document

Malignant neoplasm of the endometrium - Hormonal replacement therapy Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Medical Report - Hormone Replacement Medication - Malignant Neoplasm of the Endometrium [MR9086]

Preliminary questions [14041]

1169the veteran is a woman.

9172

the veteran has had a course of hormone replacement therapy at some time.

8813 the veteran has undergone a course of hormone replacement medication consisting of oestrogen unopposed by progesterone at some time.

8814

the course of hormone replacement medication consisting of oestrogen unopposed by progesterone was undergone for treatment of an illness or injury which is identifiable.

14102

the veteran underwent the course of hormone replacement medication consisting of oestrogen unopposed by progesterone for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium.

14103the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and VEA service for the clinical onset of malignant neoplasm of the endometrium.

14104the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and operational service for the clinical onset of malignant neoplasm of the endometrium.

or

14105the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and eligible service for the clinical onset of malignant neoplasm of the endometrium.

Clinical onset and operational service [14104]

8823the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service.

Clinical onset and eligible service [14105]

8824the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service.